Non-invasive Prenatal Testing Market
Non-invasive Prenatal Testing Market Study by Panel 1 Test, Panel 2 Test, and Panel 3 Test at Hospitals, Diagnostic Labs, and Maternity Centres from 2024 to 2034
Analysis of Non-invasive Prenatal Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Non-Invasive Prenatal Testing Market Outlook (2024 to 2034)
The global non-invasive prenatal testing (NIPT) market size is estimated to attain a valuation of US$ 1,447.2 million in 2024. During the forecast period, 2024 to 2034, the demand for non-invasive prenatal testing is expected to garner a 10.1% CAGR globally. By 2034, the industry is expected to have grown to a valuation of US$ 3,799.2 million.
Key Market Growth Drivers
- Technological breakthroughs that improve precision and broaden screening capabilities, such as next-generation sequencing, are a hallmark of the non-invasive prenatal testing (NIPT) market.
- A rise in acceptance rates and market expansion is a result of healthcare efforts and educational programs that raise worldwide knowledge of the advantages of NIPT.
- The increasing tendency of postponing childbirth is a notable feature of the industry, driving up demand for non-invasive prenatal testing. NIPT becomes essential for precise and timely diagnosis of chromosomal abnormalities as maternal age increases, driving market growth.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 1,447.2 million |
| Forecast Market Value (2034F) | US$ 3,799.2 million |
| Global Market Growth Rate (2024 to 2034) | 10.1% CAGR |
| Panel 1 Test Segment Growth Rate (2024 to 2034) | 10.2% CAGR |
| Hospitals Segment Growth Rate (2024 to 2034) | 10% CAGR |
| North America Market Share (2024) | 61.7% |
| Latin America Market Share (2024) | 1.1% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors are Responsible for the Growth of the Global Non-Invasive Prenatal Testing Market?
“New advancements related to genes and chromosomes to boost the demand for NIPT globally.”
New technologies are helping to drive the expansion of the non-invasive prenatal testing (NIPT) market. The precision and scope of genetic analysis are improved by innovations such as next-generation sequencing (NGS), which makes thorough screening for chromosomal defects possible. These technologies provide a non-invasive substitute for conventional invasive treatments by making it easier to identify fetal DNA in mother blood.
Expanded panels of tests that include new genetic markers further enhance enhanced diagnosis accuracy. The amalgamation of artificial intelligence and machine learning algorithms facilitates the interpretation of data and analysis of results, guaranteeing more dependable outputs. All of these improvements increase the effectiveness, use, and consistency of NIPT, which promotes its broad use around the world.
“Increasing maternal age due to delayed pregnancies to boost the global market growth.”
The global increase in maternal age is a major factor driving the non-invasive prenatal testing (NIPT) market. The risk of chromosomal abnormalities increases when women postpone motherhood, increasing the need for precise and timely screening techniques. Since NIPT is non-invasive, it presents a safer option than conventional invasive techniques.
The method is widely used because of its excellent sensitivity and specificity as well as improvements like larger testing panels. The market is expanding because of the growing knowledge of NIPT's advantages among expectant parents and healthcare professionals. As the landscape of maternal and fetal healthcare changes, NIPT is becoming an essential tool for prenatal screening.
What are the Major Restraints to the Growth of the Non-Invasive Prenatal Testing Market?
“Ethical Considerations regarding Abortions to pose a Considerable Challenge to Market Expansion.”
The market for non-invasive prenatal testing (NIPT) must overcome obstacles including the requirement for broad expertise, ensuring cost, and negotiating various regulatory frameworks throughout the globe.
Obstacles include possible false positives and ethical worries about selective abortions based on test findings. The shifting market necessitates ongoing innovation, increasing the bar for technology and testing requirements.
There are still many obstacles to overcome before market participants can build a long-lasting and inclusive presence in the competitive NIPT market. These include handling the ethical implications of genetic testing, guaranteeing equitable accessibility, and resolving healthcare inequities.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Startups Trying to Establish a Strong Position in the Global Non-Invasive Prenatal Testing Market?
“Startups are emphasizing on age and patient-centric approached in the global market.”
Innovative tactics are being used by startups in the global non-invasive prenatal testing (NIPT) sector to establish a strong market presence. They place a high priority on technology, bringing in new testing techniques and genetic markers to improve accuracy.
Their services are characterized by agile and patient-centric methods, with competitive pricing models frequently available. Strategic alliances and joint ventures with medical experts bolster market presence.
In order to ensure widespread acceptance, startups use digital marketing and educational activities to build awareness. They are also putting a focus on compliance and data protection that fosters trust. In general, startups are positioned as significant contributors to the changing landscape of NIPT services due to their emphasis on technology, accessibility, and cooperative partnerships.
Country-wise Insights
The non-invasive prenatal testing market demand is accelerating in North America and East Asia. In 2024, the North America non-invasive prenatal testing market is poised to gain a 61.7% market share. The market for non-invasive prenatal testing (NIPT) in North America is being pushed by rising maternal age groups, a focus on precise and early screening, and improvements in prenatal care technology.
In comparison, it is projected that by 2024, East Asia would reach a market share of 1.1%. The market for non-invasive prenatal testing (NIPT) in Latin America is being pushed by factors such as increased acceptance of NIPT services, improved healthcare infrastructure, as well as a growing emphasis on advanced prenatal care.
What makes the United States a Potential Market for Non-Invasive Prenatal Testing?
“Robust insurance coverage and advanced healthcare infrastructure to bolster demand in the U.S.”
| Attributes | The United States |
|---|---|
| Market Value in 2024 | US$ 859 million |
| CAGR from 2024 to 2034 | 10.6% |
| Projected Value in 2034 | US$ 2,346 million |
The market in the United States is expected to be valued at US$ 859 million in 2024, anticipated to gain a market share of 96.1% in 2024. Demand in the non-invasive prenatal testing (NIPT) market is driven by an increase in the number of aging mothers as well as an increasing emphasis on precise and timely prenatal screening. Broad accessibility is facilitated by sophisticated insurance policies and a state-of-the-art healthcare infrastructure.
New technological developments, such as larger genetic panels and more accurate testing techniques, contribute to the market's continued expansion. Furthermore, NIPT adoption is bolstered by aggressive public awareness efforts and partnerships between healthcare practitioners and testing providers, underscoring the test's critical role in prenatal care.
What will be the Outlook of the Non-Invasive Prenatal Testing Demand in Brazil?
“Increased focus on prenatal care is boosting the demand in Brazil.”
| Attributes | Brazil |
|---|---|
| Market Value in 2024 | US$ 8 million |
| CAGR from 2024 to 2034 | 9% |
| Projected Value in 2034 | US$ 20 million |
In 2024, the Brazil market for non-invasive prenatal testing is expected to be valued at US$ 8 million. The industry is also projected to acquire a market share of 51.5% in the same year.
Growing prenatal care focus, improved healthcare infrastructure, and rising awareness are driving Brazil's non-invasive prenatal testing (NIPT) market. Adoption of modern technologies such next-generation sequencing (NGS), which improves the accuracy and scope of NIPT, is a prime instance of innovation in the entire country.
Brazil is committed to providing advanced prenatal screening, as seen by the addition of new genetic markers and larger testing panels. These innovations help the industry flourish by giving pregnant parents more accurate and complete information about fetal health.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which will be the Most Preferred Type of Non-invasive Prenatal Test?
“The panel 1 non-invasive prenatal testing is likely to be highly preferred.”
| By Test Type | Value Share in 2024 |
|---|---|
| Panel Test 1 | 59.6% |
The panel test 1 segment is estimated to hold 59.6% of the market share in 2024. During the forecast period, the segment is anticipated to garner a 10.2% CAGR. Panel 1 non-invasive prenatal tests are favored for their complete screening capabilities in the global NIPT market.
These tests provide expecting parents comprehensive information about the health of the fetus by analyzing a wide spectrum of chromosomal abnormalities. Increased diagnostic precision from the broader coverage affects broad adoption.
Their non-invasiveness also guarantees the safety of the fetus and the mother. Panel 1 NIPT is a popular option in the changing prenatal testing environment since it is convenient for evaluating many genetic disorders in a single test.
Which is the Most Common End User of Non-invasive Prenatal Testing (NIPT) market?
“Non-invasive prenatal testing is highly being conducted in the Hospitals.”
| By End User | Value Share in 2024 |
|---|---|
| Hospitals | 53.4% |
In 2024, the hospital segment is likely to gain a market share of 53.4%.Since non-invasive prenatal testing (NIPT) is safe and accurate; it is widely used in hospitals. Hospitals offer a hygienic and regulated setting that guarantees accurate sample collection for trustworthy outcomes. The procedure's non-invasive nature reduces hazards, making it a popular option among pregnant women.
Hospitals that provide access to qualified medical personnel guarantee appropriate counseling and result interpretation, providing pregnant parents with all-encompassing care. This supports the healthcare industry's dedication to offering sophisticated and secure prenatal screening alternatives, which helps explain why NIPT is so widely used in hospital settings.
Competitive Landscape
In order to increase sales, companies in the global non-invasive prenatal testing (NIPT) market are deliberately concentrating on market expansion and innovation.
They make large investments in research and development with the goal of improving the range and precision of prenatal diagnostic technology. Customer awareness is raised by marketing campaigns that highlight NIPT's high detection rates and non-invasive nature.
Market penetration is strengthened by partnerships with genetic counseling services and healthcare providers. Companies also look at regulatory clearances and developing markets in order to broaden their global reach. These organizations want to take a bigger chunk of the expanding NIPT industry by being on the cutting edge of technology and market trends.
Few of the key players in this market are Genesis Genetics (CooperSurgical, Inc.), Natera Inc., Eurofins LifeCodexx GmbH, Illumina Inc. (Verinata Health Inc.), Centogene N.V., MedGenome Labs Ltd., Myriad Women’s Health Inc. (Counsyl Inc.), F. Hoffmann La-Roche Ltd. (Ariosa Diagnostics), Qiagen, Laboratory Corp. of America Holdings, Progenity Inc.
Some of the key developments in this market are:
- In 2023, Natera, Inc. a global pioneer in cell-free DNA testing, established a deal with Merck, known as MSD outside the US and Canada, under which Merck would use Natera's real-world database (RWD) to improve cancer research.
- De-identified clinical and genomic data from over 100,000 cancer patients in both early and late stages who underwent testing with SignateraTM, the company's customized and tumor-informed molecular residual disease (MRD) test, are included in Natera's oncology RWD.
Segmentation of Non-Invasive Prenatal Testing Market Research
-
Test Type :
- Panel 1 Test
- Panel 2 Test
- Panel 3 Test
-
End User :
- Hospitals
- Diagnostic Labs
- Maternity Centres
-
Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019-2023 and Forecast, 2024-2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019-2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024-2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Test Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2019-2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2024-2034 5.3.1. Panel 1 Test 5.3.2. Panel 2 Test 5.3.3. Panel 3 Test 5.4. Y-o-Y Growth Trend Analysis By Test Type, 2019-2023 5.5. Absolute $ Opportunity Analysis By Test Type, 2024-2034 6. Global Market Analysis 2019-2023 and Forecast 2024-2034, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019-2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024-2034 6.3.1. Hospitals 6.3.2. Diagnostic Laboratories 6.3.3. Maternity Centres 6.4. Y-o-Y Growth Trend Analysis By End User, 2019-2023 6.5. Absolute $ Opportunity Analysis By End User, 2024-2034 7. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019-2023 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024-2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Test Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Test Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Test Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Test Type 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Test Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test Type 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Test Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Test Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test Type 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2019-2023 and Forecast 2024-2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Test Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Test Type 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019-2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024-2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Test Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Test Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Test Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Test Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Test Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Test Type 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Test Type 15.5.2.2. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Test Type 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Test Type 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Test Type 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Test Type 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Test Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Test Type 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Test Type 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Test Type 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Test Type 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Test Type 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Test Type 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Test Type 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Test Type 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Test Type 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Test Type 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Test Type 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Test Type 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Test Type 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Test Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Genesis Genetics (CooperSurgical, Inc.) 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Natera, Inc. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Eurofins LifeCodexx GmbH 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Illumina, Inc. (Verinata Health, Inc.) 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Centogene N.V. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. MedGenome Labs Ltd. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Myriad Women’s Health, Inc. (Counsyl, Inc.) 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Qiagen 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Laboratory Corp. of America Holdings 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Progenity, Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019-2034
Table 2: Global Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 3: Global Market Value (US$ Million) Forecast by End User, 2019-2034
Table 4: North America Market Value (US$ Million) Forecast by Country, 2019-2034
Table 5: North America Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 6: North America Market Value (US$ Million) Forecast by End User, 2019-2034
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2019-2034
Table 8: Latin America Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2019-2034
Table 10: Western Europe Market Value (US$ Million) Forecast by Country, 2019-2034
Table 11: Western Europe Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 12: Western Europe Market Value (US$ Million) Forecast by End User, 2019-2034
Table 13: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019-2034
Table 14: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 15: Eastern Europe Market Value (US$ Million) Forecast by End User, 2019-2034
Table 16: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019-2034
Table 17: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 18: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2019-2034
Table 19: East Asia Market Value (US$ Million) Forecast by Country, 2019-2034
Table 20: East Asia Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 21: East Asia Market Value (US$ Million) Forecast by End User, 2019-2034
Table 22: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019-2034
Table 23: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2019-2034
Table 24: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2019-2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Test Type, 2024-2034
Figure 2: Global Market Value (US$ Million) by End User, 2024-2034
Figure 3: Global Market Value (US$ Million) by Region, 2024-2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019-2034
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2024-2034
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2024-2034
Figure 7: Global Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 8: Global Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 9: Global Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 13: Global Market Attractiveness by Test Type, 2024-2034
Figure 14: Global Market Attractiveness by End User, 2024-2034
Figure 15: Global Market Attractiveness by Region, 2024-2034
Figure 16: North America Market Value (US$ Million) by Test Type, 2024-2034
Figure 17: North America Market Value (US$ Million) by End User, 2024-2034
Figure 18: North America Market Value (US$ Million) by Country, 2024-2034
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 22: North America Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 23: North America Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 24: North America Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 28: North America Market Attractiveness by Test Type, 2024-2034
Figure 29: North America Market Attractiveness by End User, 2024-2034
Figure 30: North America Market Attractiveness by Country, 2024-2034
Figure 31: Latin America Market Value (US$ Million) by Test Type, 2024-2034
Figure 32: Latin America Market Value (US$ Million) by End User, 2024-2034
Figure 33: Latin America Market Value (US$ Million) by Country, 2024-2034
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 37: Latin America Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 43: Latin America Market Attractiveness by Test Type, 2024-2034
Figure 44: Latin America Market Attractiveness by End User, 2024-2034
Figure 45: Latin America Market Attractiveness by Country, 2024-2034
Figure 46: Western Europe Market Value (US$ Million) by Test Type, 2024-2034
Figure 47: Western Europe Market Value (US$ Million) by End User, 2024-2034
Figure 48: Western Europe Market Value (US$ Million) by Country, 2024-2034
Figure 49: Western Europe Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 50: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 51: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 52: Western Europe Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 53: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 54: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 55: Western Europe Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 56: Western Europe Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 57: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 58: Western Europe Market Attractiveness by Test Type, 2024-2034
Figure 59: Western Europe Market Attractiveness by End User, 2024-2034
Figure 60: Western Europe Market Attractiveness by Country, 2024-2034
Figure 61: Eastern Europe Market Value (US$ Million) by Test Type, 2024-2034
Figure 62: Eastern Europe Market Value (US$ Million) by End User, 2024-2034
Figure 63: Eastern Europe Market Value (US$ Million) by Country, 2024-2034
Figure 64: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 65: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 66: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 67: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 68: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 69: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 70: Eastern Europe Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 71: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 72: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 73: Eastern Europe Market Attractiveness by Test Type, 2024-2034
Figure 74: Eastern Europe Market Attractiveness by End User, 2024-2034
Figure 75: Eastern Europe Market Attractiveness by Country, 2024-2034
Figure 76: South Asia and Pacific Market Value (US$ Million) by Test Type, 2024-2034
Figure 77: South Asia and Pacific Market Value (US$ Million) by End User, 2024-2034
Figure 78: South Asia and Pacific Market Value (US$ Million) by Country, 2024-2034
Figure 79: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 80: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 81: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 82: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 83: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 84: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 85: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 86: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 87: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 88: South Asia and Pacific Market Attractiveness by Test Type, 2024-2034
Figure 89: South Asia and Pacific Market Attractiveness by End User, 2024-2034
Figure 90: South Asia and Pacific Market Attractiveness by Country, 2024-2034
Figure 91: East Asia Market Value (US$ Million) by Test Type, 2024-2034
Figure 92: East Asia Market Value (US$ Million) by End User, 2024-2034
Figure 93: East Asia Market Value (US$ Million) by Country, 2024-2034
Figure 94: East Asia Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 95: East Asia Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 97: East Asia Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 98: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 99: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 100: East Asia Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 101: East Asia Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 102: East Asia Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 103: East Asia Market Attractiveness by Test Type, 2024-2034
Figure 104: East Asia Market Attractiveness by End User, 2024-2034
Figure 105: East Asia Market Attractiveness by Country, 2024-2034
Figure 106: Middle East and Africa Market Value (US$ Million) by Test Type, 2024-2034
Figure 107: Middle East and Africa Market Value (US$ Million) by End User, 2024-2034
Figure 108: Middle East and Africa Market Value (US$ Million) by Country, 2024-2034
Figure 109: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019-2034
Figure 110: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 111: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 112: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2019-2034
Figure 113: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2024-2034
Figure 114: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2024-2034
Figure 115: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2019-2034
Figure 116: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2024-2034
Figure 117: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2024-2034
Figure 118: Middle East and Africa Market Attractiveness by Test Type, 2024-2034
Figure 119: Middle East and Africa Market Attractiveness by End User, 2024-2034
Figure 120: Middle East and Africa Market Attractiveness by Country, 2024-2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What was the estimated value of the non-invasive prenatal testing market in 2019?
The global non-invasive prenatal testing market was valued at US$ 882.9 million in 2019.
What will be the outlook of the non-invasive prenatal testing market in 2024?
The global market for non-invasive prenatal testing is likely to be valued at US$ 1,447.2 million in 2024.
What is the market value for non-invasive prenatal testing in 2034?
The scope for non-invasive prenatal testing is projected to reach a market value of US$ 3,799.2 million by 2034.
What is the adoption CAGR for non-invasive prenatal testing from 2024 to 2034?
Adoption of non-invasive prenatal testing is projected to develop at a CAGR of 10.1% through 2034.
At what rate is the market in North America predicted to rise?
The North America market for non-invasive prenatal testing is projected to garner a CAGR of 10.5% through 2034.
Non-invasive Prenatal Testing Market